MedTrace Logo

Characterisation of Human B Cell Maturation in Response to Vaccination

NCT03535779 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2018-06-20

No results posted yet for this study

Summary

This study is an exploratory single site sample collection study at St Mary's hospital campus, Imperial College London. Sixteen participants scheduled to receive routine immunizations for Td/IPV (group 1) and HBsAg (group 2) will be recruited overall. Eights participants will be allocated to group 1 and eights participants to group 2 depending on their immunisation regime.

Conditions

Interventions

BIOLOGICAL

Hepatitis B

The Hepatitis B virus, is a double stranded DNA virus that prevents Hepatitis B in the population

BIOLOGICAL

Tetanus Toxoid

The Tetanus vaccine, also known as tetanus toxoid (Td/IVP), is an inactive vaccine used to prevent tetanus in the population

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2017-06-15
Completion
2018-03-13

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535779 on ClinicalTrials.gov